Renaissance Technologies (RenTech)'s MANE Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 81,852 shares of Veradermics, Incorporated (MANE) worth $10.06 M, representing 0.01% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Renaissance Technologies (RenTech) has initiated a new position in MANE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Veradermics Incorporated (MANE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Veradermics Incorporated (MANE) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +81,852 | New Buy | 81,852 | $122.94 |
Renaissance Technologies (RenTech)'s Veradermics Incorporated Investment FAQs
Renaissance Technologies (RenTech) first purchased Veradermics, Incorporated (MANE) in Q2 2026, acquiring 81,852 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Veradermics, Incorporated (MANE) for 1 quarters since Q2 2026.
Renaissance Technologies (RenTech)'s largest addition to Veradermics, Incorporated (MANE) was in Q2 2026, adding 81,852 shares worth $10.06 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 81,852 shares of Veradermics, Incorporated (MANE), valued at approximately $10.06 M.
As of the Q2 2026 filing, Veradermics, Incorporated (MANE) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Veradermics, Incorporated (MANE) was 81,852 shares, as reported at the end of Q2 2026.